Simcere Pharmaceutical Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: HK0000658531
HKD
13.09
-0.55 (-4.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate 4.39% of over the last 5 years

 
2

Flat results in Dec 24

3

With ROE of 10.60%, it has a Very Expensive valuation with a 4.67 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 30,731 Million ()

stock-summary
P/E

44.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.06

stock-summary
Return on Equity

12.25%

stock-summary
Price to Book

3.88

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.16%
0%
-6.16%
6 Months
2.27%
0%
2.27%
1 Year
84.63%
0%
84.63%
2 Years
95.08%
0%
95.08%
3 Years
30.12%
0%
30.12%
4 Years
37.79%
0%
37.79%
5 Years
66.54%
0%
66.54%

Simcere Pharmaceutical Group Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.74%
EBIT Growth (5y)
4.39%
EBIT to Interest (avg)
9.10
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.71
Tax Ratio
10.61%
Dividend Payout Ratio
55.26%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.17%
ROE (avg)
13.53%
Valuation key factors
Factor
Value
P/E Ratio
44
Industry P/E
Price to Book Value
4.67
EV to EBIT
35.67
EV to EBITDA
25.82
EV to Capital Employed
5.15
EV to Sales
4.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.45%
ROE (Latest)
10.60%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Simcere Pharmaceutical Group Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -0.64% vs 21.95% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -26.95% vs -40.22% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,301.60",
          "val2": "7,348.30",
          "chgp": "-0.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "943.90",
          "val2": "836.00",
          "chgp": "12.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "38.20",
          "val2": "40.00",
          "chgp": "-4.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-36.30",
          "val2": "243.00",
          "chgp": "-114.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "788.90",
          "val2": "1,079.90",
          "chgp": "-26.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "82.40%",
          "val2": "69.00%",
          "chgp": "1.34%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
7,301.60
7,348.30
-0.64%
Operating Profit (PBDIT) excl Other Income
943.90
836.00
12.91%
Interest
38.20
40.00
-4.50%
Exceptional Items
-36.30
243.00
-114.94%
Consolidate Net Profit
788.90
1,079.90
-26.95%
Operating Profit Margin (Excl OI)
82.40%
69.00%
1.34%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -0.64% vs 21.95% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -26.95% vs -40.22% in Dec 2022

stock-summaryCompany CV
About Simcere Pharmaceutical Group Ltd. stock-summary
stock-summary
Simcere Pharmaceutical Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available